Day One Biopharmaceuticals Inc (DAWN)
Cost of Revenue
$6.08M
Quarterly · Period ending: · USD
DAWN Cost of Revenue
Latest reported$6.08Mperiod ending
Latest reported$6.08Mperiod ending
DAWN Quarterly Cost of Revenue ($0.00 → $6.08M)
Quarterly cost of revenue
High-resolution chart · PNG
DAWN cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 6,081,000 | |
| 4,480,000 | |
| 3,765,000 | |
| 2,884,000 | |
| 2,982,000 | |
| 1,590,000 | |
| 707,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |